polyfarmacie daily use of 5 medications or more Polypharmacy
Conditions
Interventions
Intervention: integral medication review including a consultation with GP,
augmented with sophisticated medication review software (*Clinical Rules
Engine* (CRE)) and including an explicit assessmen
GPs are roughly informed about the
intervention and are stimulated to evaluate the prescribed medication of the
patients participating in the study, in their usual way.
Sponsors
Universiteit Maastricht
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: Patients aged * 60 years with at least 5 chronic medication prescriptions in at least two different organ systems.
Exclusion criteria
Exclusion criteria: Patients who cannot act for themselves, patients with insufficient knowledge of Dutch language, patients with a life-expectancy of less than one year.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome measure is treatment satisfaction measured with the Treatment Satisfaction Questionnaire for Medication (TSQM-II). . | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcome measures are: a. Patient related: medication adherence, measured with the Medication Adherence Report Scale (MARS-5), and quality of life measured with EQ-5D . b. Medication related: Drug Burden Index, changes in medication prescriptions, number and type of alerts (all extracted by CRE). c. Process related: time needed in general practice (by GP and nurse practitioner) and by the community pharmacist; number of contacts between GP and medical specialist to discuss medication changes; satisfaction of patients and professionals with CRE-OPT. | — |
Countries
Netherlands
Outcome results
None listed